These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21253523)

  • 1. Brain imaging of nicotinic receptors in Alzheimer's disease.
    Wu J; Ishikawa M; Zhang J; Hashimoto K
    Int J Alzheimers Dis; 2010 Dec; 2010():548913. PubMed ID: 21253523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent development of radioligands for imaging α7 nicotinic acetylcholine receptors in the brain.
    Toyohara J; Wu J; Hashimoto K
    Curr Top Med Chem; 2010; 10(15):1544-57. PubMed ID: 20583992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
    Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
    PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.
    Nordberg A
    Biol Psychiatry; 2001 Feb; 49(3):200-10. PubMed ID: 11230871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
    Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
    Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease.
    Meyer PM; Tiepolt S; Barthel H; Hesse S; Sabri O
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):376-86. PubMed ID: 25387119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of 1,4-Diazobicylco[3.2.2]nonane derivatives as α7-Nicotinic acetylcholine receptor PET/CT imaging agents and agonists for Alzheimer's disease.
    Wang S; Fang Y; Wang H; Gao H; Jiang G; Liu J; Xue Q; Qi Y; Cao M; Qiang B; Zhang H
    Eur J Med Chem; 2018 Nov; 159():255-266. PubMed ID: 30296684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central in vivo nicotinic acetylcholine receptor imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT).
    Ogawa M; Tsukada H; Hatano K; Ouchi Y; Saji H; Magata Y
    Biol Pharm Bull; 2009 Mar; 32(3):337-40. PubMed ID: 19252274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain.
    Sihver W; Långström B; Nordberg A
    Acta Neurol Scand Suppl; 2000; 176():27-33. PubMed ID: 11261802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human Subjects.
    Ishikawa M; Sakata M; Toyohara J; Oda K; Ishii K; Wu J; Yoshida T; Iyo M; Ishiwata K; Hashimoto K
    Clin Psychopharmacol Neurosci; 2011 Dec; 9(3):111-6. PubMed ID: 23430308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nicotinic receptors in the human brain.
    Paterson D; Nordberg A
    Prog Neurobiol; 2000 May; 61(1):75-111. PubMed ID: 10759066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.
    Toyohara J; Hashimoto K
    Open Med Chem J; 2010 May; 4():37-56. PubMed ID: 21249164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain.
    Horti AG; Villemagne VL
    Curr Pharm Des; 2006; 12(30):3877-900. PubMed ID: 17073685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease.
    Matsuura Y; Ueda M; Higaki Y; Sano K; Saji H; Enomoto S
    Mol Imaging Biol; 2019 Jun; 21(3):519-528. PubMed ID: 30047036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
    Kendziorra K; Wolf H; Meyer PM; Barthel H; Hesse S; Becker GA; Luthardt J; Schildan A; Patt M; Sorger D; Seese A; Gertz HJ; Sabri O
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):515-25. PubMed ID: 21069319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural nAChRs PET imaging probes.
    Mo YX; Yin YF; Li YM
    Nucl Med Commun; 2014 Feb; 35(2):135-43. PubMed ID: 24240192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 9-fluorenone derivatives for SPECT imaging of α7-nicotinic acetylcholine receptor.
    Gao H; Wang S; Qi Y; He G; Qiang B; Wang S; Zhang H
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126724. PubMed ID: 31624040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.